InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Lema Gerald, 董事. Officer active across 1 company, notably FIBROGEN INC. Aggregated, 3 reports have been recorded. History available since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lema Gerald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
8,289 股0Common StockSEC:0001209191-23-036077:0
15,777 股0Common StockSEC:0001209191-22-038599:0
4,700 股0Common StockSEC:0001209191-21-036682:0
3 条申报中的 3 条
About Lema Gerald
Gerald Lema serves as a Director at FibroGen Inc. As a board member, he contributes to overseeing the company's operations and shaping its strategy. Gerald brings expertise in the biopharmaceutical sector, helping FibroGen innovate and grow. His commitment to corporate governance is essential for ensuring transparency and accountability within the organization.
